| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.34B | 23.15B | 20.52B | 17.31B | 13.92B | 12.47B |
| Gross Profit | 7.01B | 6.70B | 5.62B | 4.77B | 4.08B | 3.86B |
| EBITDA | 4.21B | 3.85B | 3.26B | 2.45B | 2.01B | 2.35B |
| Net Income | 2.53B | 2.32B | 1.90B | 1.50B | 1.50B | 1.40B |
Balance Sheet | ||||||
| Total Assets | 40.64B | 38.76B | 37.55B | 33.27B | 29.64B | 27.21B |
| Cash, Cash Equivalents and Short-Term Investments | 4.04B | 2.95B | 4.75B | 4.38B | 5.60B | 6.61B |
| Total Debt | 8.95B | 8.50B | 9.77B | 8.30B | 7.26B | 6.54B |
| Total Liabilities | 17.91B | 17.50B | 18.41B | 15.58B | 13.09B | 11.89B |
| Stockholders Equity | 21.85B | 20.45B | 18.32B | 16.92B | 16.02B | 14.94B |
Cash Flow | ||||||
| Free Cash Flow | 2.07B | 1.34B | 86.68M | -1.48B | -1.82B | -133.13M |
| Operating Cash Flow | 3.78B | 3.27B | 3.37B | 1.86B | 1.32B | 2.08B |
| Investing Cash Flow | -3.39B | -3.19B | -3.50B | -3.04B | -1.95B | -3.41B |
| Financing Cash Flow | -2.51B | -1.80B | 51.86M | -124.70M | 149.24M | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$40.98B | 12.46 | 12.26% | 1.39% | 11.06% | 22.10% | |
70 Outperform | HK$168.45B | 17.37 | 25.44% | 4.35% | 15.87% | 39.53% | |
64 Neutral | HK$22.35B | 9.04 | 9.88% | 2.03% | -3.02% | 11.38% | |
62 Neutral | HK$13.20B | 20.23 | 4.89% | 1.02% | 4.73% | 492.16% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$13.91B | 20.10 | 8.92% | 1.37% | 35.32% | 24.24% | |
44 Neutral | HK$5.79B | -64.96 | -13.62% | ― | 8.41% | 32.02% |